The Effects of sugammadex on progesterone levels in pregnant rats
The Effects of sugammadex on progesterone levels in pregnant rats
Background: Sugammadex has been shown to de- crease the efficiency of progesterone-containing oralcontraceptive drugs which possess a steroid structure. Aims: The aim of the present study was to evaluatethe effects of sugammadex on progesterone levels inpregnant rats as well as on the physiological course ofthe pregnancy. Study Design: Animal experiment. Methods: This study was approved by the Selçuk Uni- versity Ethical Committee for Experimental AnimalResearch. Pregnant Winster Albino rats (n=26) weredivided into three groups and administered with vari- ous intravenous injections on the 7th day of pregnancy.The control group (Group K, n=6) received 1.5 mLserum physiologic, the sugammadex group (Group S,n=10) received 30 mg/kg sugammadex and the sugam- madex + rocuronium group (Group SR, n=10) received30 mg/kg sugammadex and 3.5 mg/kg rocuronium. Progesterone levels were measured and the offspringwere monitored for morphologic status.Results: Mean progesterone levels were 94.16±15.54ng/mL in Group K, 87.86±12.48 ng/mL in Group S,and 94.53±16.10 ng/mL in Group SR (p>0.05). Nostillbirth or miscarriage was observed in the rats. Themean number of offspring was 6.8±1.47 in Group K,6.5±1.35 in Group S, and 6.4±1.17 in Group SR. Theoffspring appeared macroscopically normal.Conclusion: Sugammadex does not appear to affect theprogesterone levels in pregnant rats in the first trimes-ter and the clinical course. Successful completion ofpregnancy and the absence of stillbirth or miscarriagewill guide future studies about the use of sugammadex,particularly in the first trimester of the pregnancy.
___
- 1. Bom A, Bradley M, Cameron K, Clark JK, Van Egmond J, Feilden H, et al. A novel concept of reversing neuromuscu- lar block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetichost. Angew Chem Int Ed Engl 2002;41:266-70.
- 2. Gijsenbergh F, Ramael S, Houwing N, van Iersel T. First human exposure of Org 25969, a novel agent to reverse the action of ro- curonium bromide. Anesthesiology 2005;103:695-703. [CrossRef]
- 3. Sorgenfrei IF, Norrild K, Larsen PB, Stensballe J, Ostergaard D, Prins ME, et al. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-fnding and safety study. Anesthesiology 2006;104:667-74. [CrossRef]
- 4. Bom A, Clark JK, Palin R. New approaches to reversal of neuro- muscular block. Curr Opin Drug Discov Devel 2002;5:793-800.
- 5. Baillard C, Clech C, Catineau J, Salhi F, Gehan G, Cupa M, et al. Postoperative residual neuromuscular block: a survey of management. Br J Anaesth 2005;95:622-6. [CrossRef]
- 6. Bowman WC. Neuromuscular block. Br J Pharmacol 2006;147:277-86. [CrossRef]
- 7. European Medicines Agency. Available from: http://www.ema. europa.eu/docs/en_GB/document_library/EPAR_-_Product_In- formation/human/000885/WC500052310.pdf.
- 8. Peplow PV. Effects of progesterone withdrawal on uterine pros- taglandin levels in the ovariectomized pregnant rat. Prostaglan- dins Leukot Essent Fatty Acids 1991;44:259-61. [CrossRef]
- 9. Bennett JP, Vallance DK, Vickery BH. The synchronization of ovulation in the adult female rat by oral administration of megestrol acetate. J Reprod Fertil 1968;16:159-63. [CrossRef]
- 10. Mirakhur RK. Sugammadex in clinicalpractice. Anaesthesia 2009,64:45-54. [CrossRef]
- 11. Hogg RM, Mirakhur RK. Sugammadex a selective relaxant binding agent for reversal of neuromuskuler block. Expert Rev Neurother 2009;9:599-608. [CrossRef]
- 12. Rezonja K, Sostaric M, Vidmar G, Mars T. Dexamethasone produces dose dependent inhibition of sugammadex reversal in in vitro innervated primary human muscle ells. Anesth Analg 2014;118:755-63. [CrossRef]
- 13. Eikermann M, Zaremba S, Malhotra A, Jordan AS, Rosowand C, Chamberlin NL. Neostigmine but not sugammadex impair supper airway dilato rmuscle activity and breathing. Br J An- aesth 2008;101:344-9. [CrossRef]
- 14. Kalkan Y, Tumkaya L, Bostan H, Tomak Y, Yılmaz A. Effects of sugammadex on immunoreactivity of calcineurin in rat tes- tes cell safter neuromuscular block: a pilot study. J Mol Histol 2011;9384-9.
- 15. Williamson RM, Mallaiah S, Barclav P. Rocuronium and su- gammadex for rapid seguence induction of obstetric general an- aestheia. Acta Anaesthesiol Scand 2011;55:644-99. [CrossRef]
- 16. Dao B. Vanage G, Li XJ, Bardin CW, Koide SS. Comparative ef- fectiveness of three antiprogestins aloneand in combination with anordiol interminating pregnancy in the rat potent combination was ORG 31806 plus anordiol. Contraception 1997;55:35-40. [CrossRef]
- 17. Chwalisz K, Winter E, Thomas H. Robert TE. Synergistic role of nitric oxide and progesterone during the establishment of preg- nancy in the rat. Human Reprod 1999;14:42-552. [CrossRef]
- 18. Elger W, Bartley J, Schneider B, Kaufmann G, Schubert G, Chwalisz K. Endocrine pharmacological characterization of progesterone antagonists and progesterone receptor modulators with respect to PR-agonistic and antagonistic activity. Steroids 2000;65:713-23. [CrossRef]
- 19. Vodstrcil LA, Shynlova O, Westcott K, Simpson RLE, Wlodek ME, et al. Progesterone withdrawal, and not increased circulat- ing relaxin, mediates the decrease in myometrial relaxin recep- tor (RXFP1) expression in late gestation in rats. Biol Reprod 2010;83:825-32. [CrossRef]
- 20. Yang B, Zhou HJ, He QJ, Fang RY. Termination of early preg- nancy in the mouse, rat and hamster with DL111-IT and RU486. Contraception 2000;62:211-6. [CrossRef]
- 21. Lv XH1, Shi da Z. Variations of serum estradiol and proges- terone levels during consecutive reproductive states in Mongo- lian gerbils (Meriones unguiculatus). Exp Anim 2010;59:231-7. [CrossRef]
- 22. Mete F, Kilic E, Somay A, Yilmaz B. Effects of heat stress on endocrine functions&behaviour in the pre-pubertal rat. Indian J Med Res 2012;135:233-9.
- 23. Kayashima K, Sozen R, Okura D. Insuffcient sugammadex ef- fect in an obese pregnant woman undergoing cesarean section under general anesthesia. Masui 2014;63:188-90.
- 24. Hamada K, Kayashima K. Management of cesarean section un- der general anesthesia using sugammadex. Masui 2013;62:75-7.
- 25. Nauheimer D, Kollath C, Geldner G. Modifed rapid se - quence induction for Caesarian sections: caseseries on theuse of rocuronium and sugammadex. Anaesthesist 2012;61:691-5. [CrossRef]
- 26. Shibusawa M, Ejima Y, Nishino R, Toyama H, Kurosawa S. Use of sugammadex in patients undergoing caesarean section using general anesthesia with rocuronium. Masui 2012;61:805-9.